ChemicalName,ChemicalID,PhenotypeName,PhenotypeID,CoMentionedTerms,Organism,OrganismID,Interaction,InteractionActionsAnatomyTerms,InferenceGeneSymbols
10074-G5,C534883,,ATP biosynthetic process,GO:0006754,,Homo sapiens,9606.0,10074-G5 analog results in decreased ATP biosynthetic process,decreases^phenotype
10074-G5,C534883,,ATP biosynthetic process,GO:0006754,,Homo sapiens,9606.0,10074-G5 analog results in decreased ATP biosynthetic process,decreases^phenotype
10074-G5,C534883,,ATP biosynthetic process,GO:0006754,,Homo sapiens,9606.0,10074-G5 results in decreased ATP biosynthetic process,decreases^phenotype
10074-G5,C534883,,ATP biosynthetic process,GO:0006754,,Homo sapiens,9606.0,10074-G5 results in decreased ATP biosynthetic process,decreases^phenotype
10074-G5,C534883,,cellular lipid biosynthetic process,GO:0097384,,Homo sapiens,9606.0,10074-G5 analog results in increased cellular lipid biosynthetic process,increases^phenotype
10074-G5,C534883,,cellular lipid biosynthetic process,GO:0097384,,Homo sapiens,9606.0,10074-G5 results in increased cellular lipid biosynthetic process,increases^phenotype
10074-G5,C534883,,cellular lipid biosynthetic process,GO:0097384,,Homo sapiens,9606.0,10074-G5 results in increased cellular lipid biosynthetic process,increases^phenotype
10074-G5,C534883,,myeloid cell differentiation,GO:0030099,,Homo sapiens,9606.0,10074-G5 analog results in increased myeloid cell differentiation,increases^phenotype
10074-G5,C534883,,myeloid cell differentiation,GO:0030099,,Homo sapiens,9606.0,10074-G5 results in increased myeloid cell differentiation,increases^phenotype
10074-G5,C534883,,negative regulation of mitotic cell cycle,GO:0045930,,Homo sapiens,9606.0,10074-G5 analog results in increased negative regulation of mitotic cell cycle,increases^phenotype
"10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone",C112297,,transmission of nerve impulse,GO:0019226,,Rattus norvegicus,10116.0,"10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone results in increased transmission of nerve impulse",increases^phenotype
"10,12-octadecadienoic acid",C094849,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"10,12-octadecadienoic acid results in decreased cellular metabolic process",decreases^phenotype
"10,12-octadecadienoic acid",C094849,,fatty acid metabolic process,GO:0006631,Diquat^D004178^MESH,Mus musculus,10090.0,"[Diquat affects fatty acid metabolic process] which results in increased abundance of 10,12-octadecadienoic acid",affects^phenotype|increases^abundance
"10,12-octadecadienoic acid",C094849,,flagellated sperm motility,GO:0030317,"9,11-linoleic acid^C046938^MESH",Oryctolagus cuniculus,9986.0,"[9,11-linoleic acid co-treated with 10,12-octadecadienoic acid] results in decreased flagellated sperm motility",affects^cotreatment|decreases^phenotype
"10,12-octadecadienoic acid",C094849,,male gonad development,GO:0008584,"9,11-linoleic acid^C046938^MESH",Oryctolagus cuniculus,9986.0,"[9,11-linoleic acid co-treated with 10,12-octadecadienoic acid] results in decreased male gonad development",affects^cotreatment|decreases^phenotype
"10,12-octadecadienoic acid",C094849,,regulation of fatty acid metabolic process,GO:0019217,lard^C029310^MESH,Rattus norvegicus,10116.0,"[lard affects regulation of fatty acid metabolic process] which results in increased abundance of 10,12-octadecadienoic acid",affects^phenotype|increases^abundance
"10,12-octadecadienoic acid",C094849,,regulation of unsaturated fatty acid biosynthetic process,GO:2001279,"9,11-linoleic acid^C046938^MESH",Oryctolagus cuniculus,9986.0,"[9,11-linoleic acid co-treated with 10,12-octadecadienoic acid] affects regulation of unsaturated fatty acid biosynthetic process",affects^cotreatment|affects^phenotype
10-((3-hydroxy-4-methoxybenzylidene))-9(10H)-anthracenone,C476444,,release from viral latency,GO:0019046,,Homo sapiens,9606.0,10-((3-hydroxy-4-methoxybenzylidene))-9(10H)-anthracenone results in increased release from viral latency,increases^phenotype
10-((3-hydroxy-4-methoxybenzylidene))-9(10H)-anthracenone,C476444,,release from viral latency,GO:0019046,bryostatin 1^C046785^MESH,Homo sapiens,9606.0,bryostatin 1 promotes the reaction [10-((3-hydroxy-4-methoxybenzylidene))-9(10H)-anthracenone results in increased release from viral latency],increases^phenotype|increases^reaction
10-((3-hydroxy-4-methoxybenzylidene))-9(10H)-anthracenone,C476444,,release from viral latency,GO:0019046,prostratin^C070999^MESH,Homo sapiens,9606.0,prostratin promotes the reaction [10-((3-hydroxy-4-methoxybenzylidene))-9(10H)-anthracenone results in increased release from viral latency],increases^phenotype|increases^reaction
10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine,C553100,,cell population proliferation,GO:0008283,cobaltous chloride^C018021^MESH|HCRT^3060^GENE,Rattus norvegicus,10116.0,10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine analog inhibits the reaction [HCRT protein inhibits the reaction [cobaltous chloride results in decreased cell population proliferation]],decreases^phenotype|decreases^reaction
10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine,C553100,,positive regulation of apoptotic process,GO:0043065,Tetradecanoylphorbol Acetate^D013755^MESH,Homo sapiens,9606.0,[10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine co-treated with Tetradecanoylphorbol Acetate] results in increased positive regulation of apoptotic process,affects^cotreatment|increases^phenotype
10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine,C553100,,positive regulation of megakaryocyte differentiation,GO:0045654,THPO^7066^GENE,Homo sapiens,9606.0,10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine inhibits the reaction [THPO protein results in increased positive regulation of megakaryocyte differentiation],decreases^reaction|increases^phenotype
10-(alpha-diethylaminopropionyl)phenothiazine,C013759,63834-04-8,positive regulation of cell death,GO:0010942,,Homo sapiens,9606.0,10-(alpha-diethylaminopropionyl)phenothiazine results in increased positive regulation of cell death,increases^phenotype
10-deacetylpaclitaxel,C095360,,negative regulation of cell population proliferation,GO:0008285,,Homo sapiens,9606.0,10-deacetylpaclitaxel results in increased negative regulation of cell population proliferation,increases^phenotype
10-deacetylpaclitaxel,C095360,,response to antineoplastic agent,GO:0097327,Paclitaxel^D017239^MESH,Homo sapiens,9606.0,[Paclitaxel results in decreased response to antineoplastic agent] which results in decreased susceptibility to 10-deacetylpaclitaxel,decreases^phenotype|decreases^response to substance
10-decarbamoylmitomycin C,C067795,26909-37-5,apoptotic process,GO:0006915,,Homo sapiens,9606.0,10-decarbamoylmitomycin C results in increased apoptotic process,increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,apoptotic DNA fragmentation,GO:0006309,,Rattus norvegicus,10116.0,"10H-3,6-diazaphenothiazine results in increased apoptotic DNA fragmentation",increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,apoptotic process,GO:0006915,,Rattus norvegicus,10116.0,"10H-3,6-diazaphenothiazine results in increased apoptotic process",increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,cell chemotaxis,GO:0060326,,Homo sapiens,9606.0,"10H-3,6-diazaphenothiazine results in decreased cell chemotaxis",decreases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"10H-3,6-diazaphenothiazine affects cellular metabolic process",affects^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"10H-3,6-diazaphenothiazine affects cellular metabolic process",affects^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"10H-3,6-diazaphenothiazine results in decreased cellular metabolic process",decreases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,cellular metabolic process,GO:0044237,,Rattus norvegicus,10116.0,"10H-3,6-diazaphenothiazine affects cellular metabolic process",affects^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,cysteine-type endopeptidase activity involved in apoptotic process,GO:0097153,,Rattus norvegicus,10116.0,"10H-3,6-diazaphenothiazine results in increased cysteine-type endopeptidase activity involved in apoptotic process",increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,G0 to G1 transition,GO:0045023,"10H-3,6-diazaphenothiazine^C000627785^MESH",Homo sapiens,9606.0,"[10H-3,6-diazaphenothiazine results in increased negative regulation of mitotic cell cycle] which results in decreased G0 to G1 transition",decreases^phenotype|increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,mitotic S phase,GO:0000084,"10H-3,6-diazaphenothiazine^C000627785^MESH",Homo sapiens,9606.0,"[10H-3,6-diazaphenothiazine results in increased negative regulation of mitotic cell cycle] which results in increased mitotic S phase",increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,necrotic cell death,GO:0070265,,Rattus norvegicus,10116.0,"10H-3,6-diazaphenothiazine results in increased necrotic cell death",increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,negative regulation of mitotic cell cycle,GO:0045930,,Homo sapiens,9606.0,"10H-3,6-diazaphenothiazine results in increased negative regulation of mitotic cell cycle",increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,negative regulation of mitotic cell cycle,GO:0045930,"10H-3,6-diazaphenothiazine^C000627785^MESH",Homo sapiens,9606.0,"[10H-3,6-diazaphenothiazine results in increased negative regulation of mitotic cell cycle] which results in decreased G0 to G1 transition",decreases^phenotype|increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,negative regulation of mitotic cell cycle,GO:0045930,"10H-3,6-diazaphenothiazine^C000627785^MESH",Homo sapiens,9606.0,"[10H-3,6-diazaphenothiazine results in increased negative regulation of mitotic cell cycle] which results in increased mitotic S phase",increases^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,reactive oxygen species metabolic process,GO:0072593,,Rattus norvegicus,10116.0,"10H-3,6-diazaphenothiazine affects reactive oxygen species metabolic process",affects^phenotype
"10H-3,6-diazaphenothiazine",C000627785,,reactive oxygen species metabolic process,GO:0072593,Reactive Oxygen Species^D017382^MESH,Rattus norvegicus,10116.0,"[10H-3,6-diazaphenothiazine affects reactive oxygen species metabolic process] which results in increased abundance of Reactive Oxygen Species",affects^phenotype|increases^abundance
"10H-3,6-diazaphenothiazine",C000627785,,regulation of mitochondrial membrane potential,GO:0051881,,Rattus norvegicus,10116.0,"10H-3,6-diazaphenothiazine affects regulation of mitochondrial membrane potential",affects^phenotype
"10-hydroperoxy-8,12-octadecadienoic acid",C058335,90540-32-2,lipid metabolic process,GO:0006629,methylmercuric chloride^C004925^MESH,Rattus norvegicus,10116.0,"[methylmercuric chloride affects lipid metabolic process] which results in decreased abundance of 10-hydroperoxy-8,12-octadecadienoic acid",affects^phenotype|decreases^abundance
10-hydroxycamptothecin,C028098,67656-30-8,apoptotic DNA fragmentation,GO:0006309,,Homo sapiens,9606.0,10-hydroxycamptothecin results in increased apoptotic DNA fragmentation,increases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,apoptotic process,GO:0006915,,Homo sapiens,9606.0,10-hydroxycamptothecin analog results in increased apoptotic process,increases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,apoptotic process,GO:0006915,Fluorouracil^D005472^MESH|Leucovorin^D002955^MESH,Homo sapiens,9606.0,[10-hydroxycamptothecin co-treated with Fluorouracil co-treated with Leucovorin] results in increased apoptotic process,affects^cotreatment|increases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,apoptotic process,GO:0006915,,Homo sapiens,9606.0,10-hydroxycamptothecin results in increased apoptotic process,increases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,apoptotic process,GO:0006915,,Homo sapiens,9606.0,10-hydroxycamptothecin results in increased apoptotic process,increases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,10-hydroxycamptothecin analog affects cell population proliferation,affects^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,10-hydroxycamptothecin results in decreased cell population proliferation,decreases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,10-hydroxycamptothecin results in decreased cell population proliferation,decreases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,cell population proliferation,GO:0008283,olomoucine^C090046^MESH,Homo sapiens,9606.0,olomoucine promotes the reaction [10-hydroxycamptothecin analog affects cell population proliferation],affects^phenotype|increases^reaction
10-hydroxycamptothecin,C028098,67656-30-8,cell population proliferation,GO:0008283,Roscovitine^D000077546^MESH,Homo sapiens,9606.0,Roscovitine promotes the reaction [10-hydroxycamptothecin analog affects cell population proliferation],affects^phenotype|increases^reaction
10-hydroxycamptothecin,C028098,67656-30-8,negative regulation of cell population proliferation,GO:0008285,,Homo sapiens,9606.0,10-hydroxycamptothecin results in increased negative regulation of cell population proliferation,increases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,negative regulation of mitotic cell cycle,GO:0045930,,Homo sapiens,9606.0,10-hydroxycamptothecin analog results in increased negative regulation of mitotic cell cycle,increases^phenotype
10-hydroxycamptothecin,C028098,67656-30-8,negative regulation of mitotic cell cycle,GO:0045930,,Homo sapiens,9606.0,10-hydroxycamptothecin results in increased negative regulation of mitotic cell cycle,increases^phenotype
10-hydroxydecanoic acid,C000621793,,fatty acid metabolic process,GO:0006631,perfluorooctanoic acid^C023036^MESH,Homo sapiens,9606.0,[perfluorooctanoic acid affects fatty acid metabolic process] which results in increased abundance of 10-hydroxydecanoic acid,affects^phenotype|increases^abundance
10-hydroxydecanoic acid,C000621793,,fatty acid metabolic process,GO:0006631,Tretinoin^D014212^MESH,Mus musculus,10090.0,[Tretinoin affects fatty acid metabolic process] which results in decreased abundance of 10-hydroxydecanoic acid,affects^phenotype|decreases^abundance
10-hydroxywarfarin,C065719,83219-99-2,xenobiotic glucuronidation,GO:0052697,,Homo sapiens,9606.0,10-hydroxywarfarin results in decreased xenobiotic glucuronidation,decreases^phenotype
10-hydroxywarfarin,C065719,83219-99-2,xenobiotic glucuronidation,GO:0052697,Zidovudine^D015215^MESH,Homo sapiens,9606.0,[10-hydroxywarfarin results in decreased xenobiotic glucuronidation] which results in decreased glucuronidation of Zidovudine,decreases^glucuronidation|decreases^phenotype
10-hydroxywarfarin,C065719,83219-99-2,xenobiotic glucuronidation,GO:0052697,,Rattus norvegicus,10116.0,10-hydroxywarfarin results in decreased xenobiotic glucuronidation,decreases^phenotype
10-hydroxywarfarin,C065719,83219-99-2,xenobiotic glucuronidation,GO:0052697,Zidovudine^D015215^MESH,Rattus norvegicus,10116.0,[10-hydroxywarfarin results in decreased xenobiotic glucuronidation] which results in decreased glucuronidation of Zidovudine,decreases^glucuronidation|decreases^phenotype
"10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-(1,4)diazepino(5',6'-4,5)thieno(3,2-f)quinolin-8-one",C549914,,nitric oxide transport,GO:0030185,Lipopolysaccharides^D008070^MESH|Nitric Oxide^D009569^MESH,Mus musculus,10090.0,"10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-(1,4)diazepino(5',6'-4,5)thieno(3,2-f)quinolin-8-one inhibits the reaction [[Lipopolysaccharides affects nitric oxide transport] which results in increased export of Nitric Oxide]",affects^phenotype|decreases^reaction|increases^export
10-nitro-oleic acid,C521487,,glutathione metabolic process,GO:0006749,,Homo sapiens,9606.0,10-nitro-oleic acid results in increased glutathione metabolic process,increases^phenotype
10-nitro-oleic acid,C521487,,glutathione metabolic process,GO:0006749,Glutathione^D005978^MESH,Homo sapiens,9606.0,[10-nitro-oleic acid results in increased glutathione metabolic process] which results in decreased abundance of Glutathione,decreases^abundance|increases^phenotype
10-nitro-oleic acid,C521487,,glutathione metabolic process,GO:0006749,Glutathione Disulfide^D019803^MESH,Homo sapiens,9606.0,[10-nitro-oleic acid results in increased glutathione metabolic process] which results in increased abundance of Glutathione Disulfide,increases^abundance|increases^phenotype
10-nitro-oleic acid,C521487,,negative regulation of cell migration,GO:0030336,,Homo sapiens,9606.0,10-nitro-oleic acid results in increased negative regulation of cell migration,increases^phenotype
10-nitro-oleic acid,C521487,,negative regulation of cell population proliferation,GO:0008285,,Homo sapiens,9606.0,10-nitro-oleic acid results in increased negative regulation of cell population proliferation,increases^phenotype
10-nitro-oleic acid,C521487,,negative regulation of cell population proliferation,GO:0008285,Probenecid^D011339^MESH,Homo sapiens,9606.0,Probenecid promotes the reaction [10-nitro-oleic acid results in increased negative regulation of cell population proliferation],increases^phenotype|increases^reaction
10-nitro-oleic acid,C521487,,negative regulation of mitotic cell cycle,GO:0045930,,Homo sapiens,9606.0,10-nitro-oleic acid results in increased negative regulation of mitotic cell cycle,increases^phenotype
10-nitro-oleic acid,C521487,,positive regulation of cell population proliferation,GO:0008284,TNF^7124^GENE,Homo sapiens,9606.0,10-nitro-oleic acid inhibits the reaction [TNF protein results in increased positive regulation of cell population proliferation],decreases^reaction|increases^phenotype
10-nitro-oleic acid,C521487,,positive regulation of NF-kappaB transcription factor activity,GO:0051092,TNF^7124^GENE,Homo sapiens,9606.0,10-nitro-oleic acid inhibits the reaction [TNF protein results in increased positive regulation of NF-kappaB transcription factor activity],decreases^reaction|increases^phenotype
10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate,C552819,,apoptotic process,GO:0006915,,Homo sapiens,9606.0,10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate results in increased apoptotic process,increases^phenotype
10-propargyl-10-deazaaminopterin,C418863,,apoptotic process,GO:0006915,Cytarabine^D003561^MESH,Homo sapiens,9606.0,[Cytarabine co-treated with 10-propargyl-10-deazaaminopterin] results in increased apoptotic process,affects^cotreatment|increases^phenotype
10-propargyl-10-deazaaminopterin,C418863,,apoptotic process,GO:0006915,Gemcitabine^D000093542^MESH,Mus musculus,10090.0,[10-propargyl-10-deazaaminopterin co-treated with Gemcitabine] results in increased apoptotic process,affects^cotreatment|increases^phenotype
10-propargyl-10-deazaaminopterin,C418863,,cell cycle,GO:0007049,Gemcitabine^D000093542^MESH,Mus musculus,10090.0,[10-propargyl-10-deazaaminopterin co-treated with Gemcitabine] affects cell cycle,affects^cotreatment|affects^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,apoptotic process,GO:0006915,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased apoptotic process",increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,apoptotic process,GO:0006915,Acetylcysteine^D000111^MESH,Homo sapiens,9606.0,"Acetylcysteine inhibits the reaction [10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased apoptotic process]",decreases^reaction|increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in decreased cellular metabolic process",decreases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,cellular response to DNA damage stimulus,GO:0006974,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased cellular response to DNA damage stimulus",increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,cellular response to DNA damage stimulus,GO:0006974,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased cellular response to DNA damage stimulus",increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,cellular response to DNA damage stimulus,GO:0006974,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH",Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased cellular response to DNA damage stimulus] which results in decreased DNA biosynthetic process",decreases^phenotype|increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,cellular response to DNA damage stimulus,GO:0006974,H2AX^3014^GENE,Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased cellular response to DNA damage stimulus] which results in increased expression of H2AX protein",increases^expression|increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,cellular response to DNA damage stimulus,GO:0006974,H2AX^3014^GENE,Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased cellular response to DNA damage stimulus] which results in increased expression of H2AX protein",increases^expression|increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,DNA binding,GO:0003677,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH",Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity] which results in increased DNA binding",increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,DNA biosynthetic process,GO:0071897,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in decreased DNA biosynthetic process",decreases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,DNA biosynthetic process,GO:0071897,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH",Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased cellular response to DNA damage stimulus] which results in decreased DNA biosynthetic process",decreases^phenotype|increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity",GO:0003918,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity",increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity",GO:0003918,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH",Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone results in increased DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity] which results in increased DNA binding",increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,G0 to G1 transition,GO:0045023,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH",Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition",affects^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,G0 to G1 transition,GO:0045023,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH|Acetylcysteine^D000111^MESH",Homo sapiens,9606.0,"Acetylcysteine inhibits the reaction [[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition]",affects^phenotype|decreases^reaction
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,G0 to G1 transition,GO:0045023,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone^C110772^MESH",Homo sapiens,9606.0,"benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition]",affects^phenotype|decreases^reaction
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,G0 to G1 transition,GO:0045023,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone^C096713^MESH",Homo sapiens,9606.0,"benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition]",affects^phenotype|decreases^reaction
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,mitotic cell cycle process,GO:1903047,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process",affects^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,mitotic cell cycle process,GO:1903047,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH",Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition",affects^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,mitotic cell cycle process,GO:1903047,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH|Acetylcysteine^D000111^MESH",Homo sapiens,9606.0,"Acetylcysteine inhibits the reaction [[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition]",affects^phenotype|decreases^reaction
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,mitotic cell cycle process,GO:1903047,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone^C110772^MESH",Homo sapiens,9606.0,"benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition]",affects^phenotype|decreases^reaction
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,mitotic cell cycle process,GO:1903047,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone^C471674^MESH|benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone^C096713^MESH",Homo sapiens,9606.0,"benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects mitotic cell cycle process] which affects G0 to G1 transition]",affects^phenotype|decreases^reaction
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,protein-DNA complex,GO:0032993,TOP2A^7153^GENE,Homo sapiens,9606.0,"[10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone binds to and results in increased activity of TOP2A protein] which results in increased protein-DNA complex",affects^binding|increases^activity|increases^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,regulation of mitochondrial membrane potential,GO:0051881,,Homo sapiens,9606.0,"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects regulation of mitochondrial membrane potential",affects^phenotype
"10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone",C471674,,regulation of mitochondrial membrane potential,GO:0051881,Acetylcysteine^D000111^MESH,Homo sapiens,9606.0,"Acetylcysteine inhibits the reaction [10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone affects regulation of mitochondrial membrane potential]",affects^phenotype|decreases^reaction
"1,10-phenanthroline",C025205,66-71-7,apoptotic process,GO:0006915,"9,10-phenanthrenequinone^C005399^MESH",Homo sapiens,9606.0,"1,10-phenanthroline inhibits the reaction [9,10-phenanthrenequinone results in increased apoptotic process]",decreases^reaction|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,apoptotic process,GO:0006915,Butylated Hydroxytoluene^D002084^MESH,Homo sapiens,9606.0,"1,10-phenanthroline inhibits the reaction [Butylated Hydroxytoluene results in increased apoptotic process]",decreases^reaction|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,apoptotic process,GO:0006915,Hydrogen Peroxide^D006861^MESH|Nitroprusside^D009599^MESH,Homo sapiens,9606.0,"1,10-phenanthroline inhibits the reaction [Hydrogen Peroxide promotes the reaction [Nitroprusside results in increased apoptotic process]]",decreases^reaction|increases^phenotype|increases^reaction
"1,10-phenanthroline",C025205,66-71-7,apoptotic process,GO:0006915,Tetrachlorodibenzodioxin^D013749^MESH,Homo sapiens,9606.0,"1,10-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin results in decreased apoptotic process]",decreases^phenotype|decreases^reaction
"1,10-phenanthroline",C025205,66-71-7,apoptotic process,GO:0006915,MBTPS2^51360^GENE,Homo sapiens,9606.0,"[1,10-phenanthroline results in decreased activity of MBTPS2 protein] which results in increased apoptotic process",decreases^activity|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,apoptotic process,GO:0006915,Antimycin A^D000968^MESH,Rattus norvegicus,10116.0,"1,10-phenanthroline affects the reaction [Antimycin A results in increased apoptotic process]",affects^reaction|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,apoptotic process,GO:0006915,Iron Compounds^D058085^MESH,Rattus norvegicus,10116.0,"1,10-phenanthroline inhibits the reaction [Iron Compounds results in increased apoptotic process]",decreases^reaction|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,ATP biosynthetic process,GO:0006754,,Homo sapiens,9606.0,"1,10-phenanthroline analog affects ATP biosynthetic process",affects^phenotype
"1,10-phenanthroline",C025205,66-71-7,cell population proliferation,GO:0008283,,Mus musculus,10090.0,"1,10-phenanthroline results in decreased cell population proliferation",decreases^phenotype
"1,10-phenanthroline",C025205,66-71-7,cellular metabolic process,GO:0044237,"9,10-phenanthrenequinone^C005399^MESH",Homo sapiens,9606.0,"1,10-phenanthroline affects the reaction [9,10-phenanthrenequinone affects cellular metabolic process]",affects^phenotype|affects^reaction
"1,10-phenanthroline",C025205,66-71-7,hydrogen peroxide catabolic process,GO:0042744,Copper^D003300^MESH|imidazole^C029899^MESH|phthalic acid^C032279^MESH,,,"[[Copper binds to phthalic acid binds to 1,10-phenanthroline] which co-treated with imidazole] results in increased hydrogen peroxide catabolic process",affects^binding|affects^cotreatment|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,hydrogen peroxide catabolic process,GO:0042744,Manganese^D008345^MESH|phthalic acid^C032279^MESH,,,"[Manganese binds to phthalic acid binds to 1,10-phenanthroline] which results in increased hydrogen peroxide catabolic process",affects^binding|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,lipid oxidation,GO:0034440,ammonium ferrous sulfate^C038178^MESH|Edetic Acid^D004492^MESH|Enzymes and Coenzymes^D045762^MESH|Flavin Mononucleotide^D005486^MESH|NADP^D009249^MESH|Sodium Chloride^D012965^MESH,Rattus norvegicus,10116.0,"1,10-phenanthroline promotes the reaction [[Flavin Mononucleotide co-treated with Sodium Chloride co-treated with Edetic Acid co-treated with ammonium ferrous sulfate co-treated with NADP metabolite co-treated with Enzymes and Coenzymes] results in increased lipid oxidation]",affects^cotreatment|increases^phenotype|increases^reaction
"1,10-phenanthroline",C025205,66-71-7,lipid oxidation,GO:0034440,ammonium ferrous sulfate^C038178^MESH|Edetic Acid^D004492^MESH|Enzymes and Coenzymes^D045762^MESH|Flavin Mononucleotide^D005486^MESH|Malondialdehyde^D008315^MESH|NADP^D009249^MESH|Sodium Chloride^D012965^MESH,Rattus norvegicus,10116.0,"1,10-phenanthroline promotes the reaction [[[Flavin Mononucleotide co-treated with Sodium Chloride co-treated with Edetic Acid co-treated with ammonium ferrous sulfate co-treated with NADP metabolite co-treated with Enzymes and Coenzymes] results in increased lipid oxidation] which results in increased abundance of Malondialdehyde]",affects^cotreatment|increases^abundance|increases^phenotype|increases^reaction
"1,10-phenanthroline",C025205,66-71-7,membrane lipid catabolic process,GO:0046466,"Asbestos, Serpentine^D017632^MESH",Rattus norvegicus,10116.0,"1,10-phenanthroline inhibits the reaction [Asbestos, Serpentine results in increased membrane lipid catabolic process]",decreases^reaction|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,,Homo sapiens,9606.0,"1,10-phenanthroline results in increased positive regulation of cell death",increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,,Homo sapiens,9606.0,"1,10-phenanthroline results in increased positive regulation of cell death",increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,,Homo sapiens,9606.0,"1,10-phenanthroline results in increased positive regulation of cell death",increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,,Homo sapiens,9606.0,"1,10-phenanthroline results in increased positive regulation of cell death",increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,Copper^D003300^MESH|phthalic acid^C032279^MESH,Homo sapiens,9606.0,"[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased positive regulation of cell death",affects^binding|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,Copper^D003300^MESH|phthalic acid^C032279^MESH,Homo sapiens,9606.0,"[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased positive regulation of cell death",affects^binding|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,Copper^D003300^MESH|phthalic acid^C032279^MESH,Homo sapiens,9606.0,"[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased positive regulation of cell death",affects^binding|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of cell death,GO:0010942,Copper^D003300^MESH|phthalic acid^C032279^MESH,Homo sapiens,9606.0,"[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased positive regulation of cell death",affects^binding|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of reactive oxygen species biosynthetic process,GO:1903428,,Homo sapiens,9606.0,"1,10-phenanthroline results in increased positive regulation of reactive oxygen species biosynthetic process",increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of reactive oxygen species biosynthetic process,GO:1903428,Copper^D003300^MESH|phthalic acid^C032279^MESH,Homo sapiens,9606.0,"[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased positive regulation of reactive oxygen species biosynthetic process",affects^binding|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,positive regulation of retinoic acid receptor signaling pathway,GO:0048386,,Mus musculus,10090.0,"1,10-phenanthroline results in increased positive regulation of retinoic acid receptor signaling pathway",increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,removal of superoxide radicals,GO:0019430,Copper^D003300^MESH|phthalic acid^C032279^MESH,,,"[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased removal of superoxide radicals",affects^binding|increases^phenotype
"1,10-phenanthroline",C025205,66-71-7,removal of superoxide radicals,GO:0019430,Copper^D003300^MESH|Hydrogen Peroxide^D006861^MESH|phthalic acid^C032279^MESH,,,"[[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased removal of superoxide radicals] which results in increased chemical synthesis of Hydrogen Peroxide",affects^binding|increases^chemical synthesis|increases^phenotype
"1,1,1,2,2-pentafluoro-7-phenylheptan-3-one",C533806,,cellular metabolic process,GO:0044237,APP^351^GENE|Orlistat^D000077403^MESH,Homo sapiens,9606.0,"[1,1,1,2,2-pentafluoro-7-phenylheptan-3-one co-treated with Orlistat] inhibits the reaction [APP protein modified form results in decreased cellular metabolic process]",affects^cotreatment|decreases^phenotype|decreases^reaction
"1,1,1,2,2-pentafluoro-7-phenylheptan-3-one",C533806,,cellular metabolic process,GO:0044237,APP^351^GENE,Homo sapiens,9606.0,"1,1,1,2,2-pentafluoro-7-phenylheptan-3-one inhibits the reaction [APP protein modified form results in decreased cellular metabolic process]",decreases^phenotype|decreases^reaction
"11,12-dihydroxyeicosatetraenoic acid",C053873,122087-32-5,arachidonic acid metabolic process,GO:0019369,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid^D019377^MESH",Homo sapiens,9606.0,"[12-Hydroxy-5,8,10,14-eicosatetraenoic Acid affects arachidonic acid metabolic process] which results in increased chemical synthesis of 11,12-dihydroxyeicosatetraenoic acid",affects^phenotype|increases^chemical synthesis
"11,12-dihydroxyeicosatetraenoic acid",C053873,122087-32-5,arachidonic acid metabolic process,GO:0019369,"5-hydroxy-6,8,11,14-eicosatetraenoic acid^C022022^MESH",Homo sapiens,9606.0,"[5-hydroxy-6,8,11,14-eicosatetraenoic acid affects arachidonic acid metabolic process] which results in increased chemical synthesis of 11,12-dihydroxyeicosatetraenoic acid",affects^phenotype|increases^chemical synthesis
"11,12-dihydroxyeicosatrienoic acid",C410128,,epoxide metabolic process,GO:0097176,EPHX1^2052^GENE|EPHX2^2053^GENE,Mus musculus,10090.0,"EPHX1 gene mutant form promotes the reaction [[EPHX2 gene mutant form results in decreased epoxide metabolic process] which results in decreased chemical synthesis of 11,12-dihydroxyeicosatrienoic acid]",decreases^chemical synthesis|decreases^phenotype|increases^reaction
"11,12-dihydroxyeicosatrienoic acid",C410128,,epoxide metabolic process,GO:0097176,EPHX2^2053^GENE,Mus musculus,10090.0,"[EPHX2 gene mutant form results in decreased epoxide metabolic process] which results in decreased chemical synthesis of 11,12-dihydroxyeicosatrienoic acid",decreases^chemical synthesis|decreases^phenotype
"11,12-dihydroxyeicosatrienoic acid",C410128,,fatty acid metabolic process,GO:0006631,Heroin^D003932^MESH,Mus musculus,10090.0,"[Heroin affects fatty acid metabolic process] which results in increased abundance of 11,12-dihydroxyeicosatrienoic acid",affects^phenotype|increases^abundance
"11,12-dihydroxyeicosatrienoic acid",C410128,,oxylipin metabolic process,GO:0031407,Docosahexaenoic Acids^D004281^MESH,Mus musculus,10090.0,"[Docosahexaenoic Acids affects oxylipin metabolic process] which results in decreased abundance of 11,12-dihydroxyeicosatrienoic acid",affects^phenotype|decreases^abundance
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,activation of protein kinase B activity,GO:0032148,,Mus musculus,10090.0,"11,12-epoxy-5,8,14-eicosatrienoic acid results in increased activation of protein kinase B activity",increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,arachidonic acid metabolic process,GO:0019369,"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid^D019377^MESH",Homo sapiens,9606.0,"[12-Hydroxy-5,8,10,14-eicosatetraenoic Acid affects arachidonic acid metabolic process] which results in decreased chemical synthesis of 11,12-epoxy-5,8,14-eicosatrienoic acid",affects^phenotype|decreases^chemical synthesis
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,endothelial tube morphogenesis,GO:0061154,Ketoconazole^D007654^MESH|VEGFA^7422^GENE,Mus musculus,10090.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Ketoconazole inhibits the reaction [VEGFA protein results in increased endothelial tube morphogenesis]]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,endothelial tube morphogenesis,GO:0061154,,Mus musculus,10090.0,"11,12-epoxy-5,8,14-eicosatrienoic acid results in increased endothelial tube morphogenesis",increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,icosanoid metabolic process,GO:0006690,sodium arsenite^C017947^MESH,Azumapecten farreri,106299.0,"[sodium arsenite affects icosanoid metabolic process] which results in increased abundance of 11,12-epoxy-5,8,14-eicosatrienoic acid",affects^phenotype|increases^abundance
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial ATP synthesis coupled electron transport,GO:1905447,Amiodarone^D000638^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Amiodarone results in increased negative regulation of mitochondrial ATP synthesis coupled electron transport]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial ATP synthesis coupled electron transport,GO:1905447,desethylamiodarone^C036116^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [desethylamiodarone results in increased negative regulation of mitochondrial ATP synthesis coupled electron transport]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial ATP synthesis coupled electron transport,GO:1905447,Dronedarone^D000077764^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Dronedarone results in increased negative regulation of mitochondrial ATP synthesis coupled electron transport]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial ATP synthesis coupled electron transport,GO:1905447,N-desbutyldronedarone^C000609888^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [N-desbutyldronedarone results in increased negative regulation of mitochondrial ATP synthesis coupled electron transport]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,Amiodarone^D000638^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Amiodarone results in increased negative regulation of mitochondrial membrane potential]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,desethylamiodarone^C036116^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [desethylamiodarone results in increased negative regulation of mitochondrial membrane potential]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,Dronedarone^D000077764^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Dronedarone results in increased negative regulation of mitochondrial membrane potential]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,N-desbutyldronedarone^C000609888^MESH,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [N-desbutyldronedarone results in increased negative regulation of mitochondrial membrane potential]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,5-hydroxydecanoic acid^C052853^MESH|Amiodarone^D000638^MESH,Rattus norvegicus,10116.0,"5-hydroxydecanoic acid inhibits the reaction [11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Amiodarone results in increased negative regulation of mitochondrial membrane potential]]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,5-hydroxydecanoic acid^C052853^MESH|desethylamiodarone^C036116^MESH,Rattus norvegicus,10116.0,"5-hydroxydecanoic acid inhibits the reaction [11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [desethylamiodarone results in increased negative regulation of mitochondrial membrane potential]]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,5-hydroxydecanoic acid^C052853^MESH|Dronedarone^D000077764^MESH,Rattus norvegicus,10116.0,"5-hydroxydecanoic acid inhibits the reaction [11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Dronedarone results in increased negative regulation of mitochondrial membrane potential]]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of mitochondrial membrane potential,GO:0010917,5-hydroxydecanoic acid^C052853^MESH|N-desbutyldronedarone^C000609888^MESH,Rattus norvegicus,10116.0,"5-hydroxydecanoic acid inhibits the reaction [11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [N-desbutyldronedarone results in increased negative regulation of mitochondrial membrane potential]]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,negative regulation of vasoconstriction,GO:0045906,,Rattus norvegicus,10116.0,"11,12-epoxy-5,8,14-eicosatrienoic acid results in increased negative regulation of vasoconstriction",increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,positive regulation of endothelial cell proliferation,GO:0001938,Ketoconazole^D007654^MESH|VEGFA^7422^GENE,Mus musculus,10090.0,"11,12-epoxy-5,8,14-eicosatrienoic acid inhibits the reaction [Ketoconazole inhibits the reaction [VEGFA protein results in increased positive regulation of endothelial cell proliferation]]",decreases^reaction|increases^phenotype
"11,12-epoxy-5,8,14-eicosatrienoic acid",C046783,,positive regulation of endothelial cell proliferation,GO:0001938,,Mus musculus,10090.0,"11,12-epoxy-5,8,14-eicosatrienoic acid results in increased positive regulation of endothelial cell proliferation",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,"1,12-benzoperylene results in decreased cell population proliferation",decreases^phenotype
"1,12-benzoperylene",C006718,191-24-2,cell population proliferation,GO:0008283,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide^C511621^MESH,Homo sapiens,9606.0,"2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1,12-benzoperylene results in decreased cell population proliferation]",decreases^phenotype|decreases^reaction
"1,12-benzoperylene",C006718,191-24-2,cellular response to DNA damage stimulus,GO:0006974,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased cellular response to DNA damage stimulus",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,cellular response to UV-A,GO:0071492,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased cellular response to UV-A",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,chemosensory behavior,GO:0007635,"1,12-benzoperylene^C006718^MESH",Danio rerio,7955.0,"[1,12-benzoperylene affects larval behavior] which affects chemosensory behavior",affects^phenotype
"1,12-benzoperylene",C006718,191-24-2,detection of oxidative stress,GO:0070994,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased detection of oxidative stress",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,detection of oxidative stress,GO:0070994,2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide^C511621^MESH,Homo sapiens,9606.0,"2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [1,12-benzoperylene results in increased detection of oxidative stress]",increases^phenotype|increases^reaction
"1,12-benzoperylene",C006718,191-24-2,DNA modification,GO:0006304,,Mus musculus,10090.0,"1,12-benzoperylene results in increased DNA modification",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,glutathione metabolic process,GO:0006749,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased glutathione metabolic process",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,glutathione metabolic process,GO:0006749,Glutathione^D005978^MESH,Homo sapiens,9606.0,"[1,12-benzoperylene results in increased glutathione metabolic process] which results in decreased abundance of Glutathione",decreases^abundance|increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,larval behavior,GO:0030537,,Danio rerio,7955.0,"1,12-benzoperylene affects larval behavior",affects^phenotype
"1,12-benzoperylene",C006718,191-24-2,larval behavior,GO:0030537,"1,12-benzoperylene^C006718^MESH",Danio rerio,7955.0,"[1,12-benzoperylene affects larval behavior] which affects chemosensory behavior",affects^phenotype
"1,12-benzoperylene",C006718,191-24-2,larval behavior,GO:0030537,"1,12-benzoperylene^C006718^MESH",Danio rerio,7955.0,"[1,12-benzoperylene affects larval behavior] which affects optomotor response",affects^phenotype
"1,12-benzoperylene",C006718,191-24-2,negative regulation of cell population proliferation,GO:0008285,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased negative regulation of cell population proliferation",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,negative regulation of superoxide dismutase activity,GO:1901670,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased negative regulation of superoxide dismutase activity",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,optomotor response,GO:0071632,"1,12-benzoperylene^C006718^MESH",Danio rerio,7955.0,"[1,12-benzoperylene affects larval behavior] which affects optomotor response",affects^phenotype
"1,12-benzoperylene",C006718,191-24-2,positive regulation of apoptotic process,GO:0043065,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased positive regulation of apoptotic process",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,positive regulation of execution phase of apoptosis,GO:1900119,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased positive regulation of execution phase of apoptosis",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,positive regulation of reactive oxygen species biosynthetic process,GO:1903428,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased positive regulation of reactive oxygen species biosynthetic process",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,positive regulation of reactive oxygen species biosynthetic process,GO:1903428,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased positive regulation of reactive oxygen species biosynthetic process",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,vesicle budding from membrane,GO:0006900,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased vesicle budding from membrane",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,vesicle organization,GO:0016050,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased vesicle organization",increases^phenotype
"1,12-benzoperylene",C006718,191-24-2,vesicle organization,GO:0016050,,Homo sapiens,9606.0,"1,12-benzoperylene results in increased vesicle organization",increases^phenotype
"1,1,3,3-tetramethylurea",C004168,632-22-4,positive regulation of natural killer cell mediated cytotoxicity,GO:0045954,,Homo sapiens,9606.0,"1,1,3,3-tetramethylurea results in decreased positive regulation of natural killer cell mediated cytotoxicity",decreases^phenotype
"1,1,3,4-tetrahydro-6-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)quinazolin-2,4-dione",C581681,,male genitalia development,GO:0030539,,Rattus norvegicus,10116.0,"1,1,3,4-tetrahydro-6-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)quinazolin-2,4-dione affects male genitalia development",affects^phenotype
"1,1,3,4-tetrahydro-6-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)quinazolin-2,4-dione",C581681,,male genitalia morphogenesis,GO:0048808,Dibutyl Phthalate^D003993^MESH,Rattus norvegicus,10116.0,"[1,1,3,4-tetrahydro-6-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)quinazolin-2,4-dione co-treated with Dibutyl Phthalate] results in decreased male genitalia morphogenesis",affects^cotreatment|decreases^phenotype
"1,1,3,4-tetrahydro-6-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)quinazolin-2,4-dione",C581681,,nipple development,GO:0060618,,Rattus norvegicus,10116.0,"1,1,3,4-tetrahydro-6-(1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl)quinazolin-2,4-dione affects nipple development",affects^phenotype
"1-(1,4-benzodioxan-6-ylcarbonyl)piperidine",C443080,,evoked excitatory postsynaptic potential,GO:0098817,,Rattus norvegicus,10116.0,"1-(1,4-benzodioxan-6-ylcarbonyl)piperidine results in increased evoked excitatory postsynaptic potential",increases^phenotype
"1-(1,4-benzodioxan-6-ylcarbonyl)piperidine",C443080,,positive regulation of neuronal action potential,GO:1904457,,Rattus norvegicus,10116.0,"1-(1,4-benzodioxan-6-ylcarbonyl)piperidine results in increased positive regulation of neuronal action potential",increases^phenotype
"1-(1,4-benzodioxan-6-ylcarbonyl)piperidine",C443080,,trans-synaptic signaling,GO:0099537,,Rattus norvegicus,10116.0,"1-(1,4-benzodioxan-6-ylcarbonyl)piperidine results in increased trans-synaptic signaling",increases^phenotype
1-(14'-methylhexadecanoyl)pyrrolidine,C432926,,heterocycle metabolic process,GO:0046483,Dextran Sulfate^D016264^MESH,Mus musculus,10090.0,[Dextran Sulfate affects heterocycle metabolic process] which results in decreased abundance of 1-(14'-methylhexadecanoyl)pyrrolidine,affects^phenotype|decreases^abundance
"1,14-tetradecanedioic acid",C441251,,fatty acid metabolic process,GO:0006631,Diquat^D004178^MESH,Mus musculus,10090.0,"[Diquat affects fatty acid metabolic process] which results in decreased abundance of 1,14-tetradecanedioic acid",affects^phenotype|decreases^abundance
"1,1,4-tris(acetyloxy)-2-nonene",C449673,,cellular response to DNA damage stimulus,GO:0006974,GSTA4^2941^GENE,Mus musculus,10090.0,"[GSTA4 gene mutant form results in increased susceptibility to 1,1,4-tris(acetyloxy)-2-nonene] which results in increased cellular response to DNA damage stimulus",increases^phenotype|increases^response to substance
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,cell redox homeostasis,GO:0045454,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in decreased cell redox homeostasis],decreases^phenotype|decreases^reaction
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,cell redox homeostasis,GO:0045454,Antioxidants^D000975^MESH|Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [[Rotenone results in decreased cell redox homeostasis] which results in increased abundance of Antioxidants],decreases^phenotype|decreases^reaction|increases^abundance
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,dopamine metabolic process,GO:0042417,Rotenone^D012402^MESH,Drosophila melanogaster,7227.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased dopamine metabolic process],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,dopamine metabolic process,GO:0042417,"3,4-Dihydroxyphenylacetic Acid^D015102^MESH|Rotenone^D012402^MESH",Drosophila melanogaster,7227.0,"1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [[Rotenone results in increased dopamine metabolic process] which results in decreased abundance of 3,4-Dihydroxyphenylacetic Acid]",decreases^abundance|decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,dopamine metabolic process,GO:0042417,Dopamine^D004298^MESH|Rotenone^D012402^MESH,Drosophila melanogaster,7227.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [[Rotenone results in increased dopamine metabolic process] which results in decreased abundance of Dopamine],decreases^abundance|decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,glutathione metabolic process,GO:0006749,Rotenone^D012402^MESH,Drosophila melanogaster,7227.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased glutathione metabolic process],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,glutathione metabolic process,GO:0006749,Glutathione^D005978^MESH|Rotenone^D012402^MESH,Drosophila melanogaster,7227.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [[Rotenone results in increased glutathione metabolic process] which affects the abundance of Glutathione],affects^abundance|decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,glutathione metabolic process,GO:0006749,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased glutathione metabolic process],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,glutathione metabolic process,GO:0006749,Glutathione^D005978^MESH|Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [[Rotenone results in increased glutathione metabolic process] which results in decreased abundance of Glutathione],decreases^abundance|decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,lipid oxidation,GO:0034440,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased lipid oxidation],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,lipid oxidation,GO:0034440,Malondialdehyde^D008315^MESH|Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [[Rotenone results in increased lipid oxidation] which results in increased abundance of Malondialdehyde],decreases^reaction|increases^abundance|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,negative regulation of cell population proliferation,GO:0008285,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased negative regulation of cell population proliferation],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,negative regulation of glutathione peroxidase activity,GO:1903283,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased negative regulation of glutathione peroxidase activity],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,"negative regulation of mitochondrial electron transport, NADH to ubiquinone",GO:1902957,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,"1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased negative regulation of mitochondrial electron transport, NADH to ubiquinone]",decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,negative regulation of superoxide dismutase activity,GO:1901670,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased negative regulation of superoxide dismutase activity],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,positive regulation of cell death,GO:0010942,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased positive regulation of cell death],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,positive regulation of mitochondrial membrane potential,GO:0010918,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in decreased positive regulation of mitochondrial membrane potential],decreases^phenotype|decreases^reaction
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,positive regulation of reactive oxygen species biosynthetic process,GO:1903428,Rotenone^D012402^MESH,Drosophila melanogaster,7227.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased positive regulation of reactive oxygen species biosynthetic process],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,positive regulation of reactive oxygen species biosynthetic process,GO:1903428,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased positive regulation of reactive oxygen species biosynthetic process],decreases^reaction|increases^phenotype
1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea,C557705,,protein oxidation,GO:0018158,Rotenone^D012402^MESH,Rattus norvegicus,10116.0,1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased protein oxidation],decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane",C534880,,locomotory behavior,GO:0007626,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in decreased locomotory behavior]",affects^cotreatment|decreases^phenotype|decreases^reaction
"1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane",C534880,,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased positive regulation of I-kappaB kinase/NF-kappaB signaling]",affects^cotreatment|decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane",C534880,,positive regulation of neuron apoptotic process,GO:0043525,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased positive regulation of neuron apoptotic process]",affects^cotreatment|decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,apoptotic process,GO:0006915,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased apoptotic process",increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,apoptotic process,GO:0006915,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased apoptotic process",increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,calcium ion homeostasis,GO:0055074,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane affects calcium ion homeostasis",affects^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell adhesion,GO:0007155,FN1^2335^GENE,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [FN1 protein results in increased cell adhesion]",decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell adhesion,GO:0007155,FN1^2335^GENE,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [FN1 protein results in increased cell adhesion]",decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell migration,GO:0016477,TGFB1^7040^GENE,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [TGFB1 protein results in increased cell migration]",decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell migration,GO:0016477,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased cell migration",decreases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell migration,GO:0016477,ITGB1^3688^GENE,Homo sapiens,9606.0,"ITGB1 protein affects the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased cell migration]",affects^reaction|decreases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell migration,GO:0016477,NR4A1^3164^GENE,Homo sapiens,9606.0,"NR4A1 protein affects the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased cell migration]",affects^reaction|decreases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell population proliferation,GO:0008283,NR4A1^3164^GENE,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane affects the reaction [NR4A1 protein affects cell population proliferation]",affects^phenotype|affects^reaction
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased cell population proliferation",decreases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased cell population proliferation",decreases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cell population proliferation,GO:0008283,NR4A1^3164^GENE,Homo sapiens,9606.0,"NR4A1 protein affects the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased cell population proliferation]",affects^reaction|decreases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,cellular response to DNA damage stimulus,GO:0006974,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cellular response to DNA damage stimulus",increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased positive regulation of I-kappaB kinase/NF-kappaB signaling]",affects^cotreatment|decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,positive regulation of neuron apoptotic process,GO:0043525,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased positive regulation of neuron apoptotic process]",affects^cotreatment|decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,reactive oxygen species biosynthetic process,GO:1903409,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased reactive oxygen species biosynthetic process",increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,reactive oxygen species biosynthetic process,GO:1903409,,Homo sapiens,9606.0,"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased reactive oxygen species biosynthetic process",increases^phenotype
"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane",C552530,,reactive oxygen species biosynthetic process,GO:1903409,Glutathione^D005978^MESH,Homo sapiens,9606.0,"Glutathione inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased reactive oxygen species biosynthetic process]",decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(p-anisyl)methane",C545255,,locomotory behavior,GO:0007626,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(p-anisyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in decreased locomotory behavior]",affects^cotreatment|decreases^phenotype|decreases^reaction
"1,1-bis(3'-indolyl)-1-(p-anisyl)methane",C545255,,positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043123,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(p-anisyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased positive regulation of I-kappaB kinase/NF-kappaB signaling]",affects^cotreatment|decreases^reaction|increases^phenotype
"1,1-bis(3'-indolyl)-1-(p-anisyl)methane",C545255,,positive regulation of neuron apoptotic process,GO:0043525,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine^D015632^MESH|Probenecid^D011339^MESH",Mus musculus,10090.0,"1,1-bis(3'-indolyl)-1-(p-anisyl)methane inhibits the reaction [[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased positive regulation of neuron apoptotic process]",affects^cotreatment|decreases^reaction|increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,cellular calcium ion homeostasis,GO:0006874,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects cellular calcium ion homeostasis",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,cellular calcium ion homeostasis,GO:0006874,Calcium^D002118^MESH,Homo sapiens,9606.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects cellular calcium ion homeostasis] which results in increased import of Calcium",affects^phenotype|increases^import
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,cellular calcium ion homeostasis,GO:0006874,Calcium^D002118^MESH|Progesterone^D011374^MESH,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene inhibits the reaction [[Progesterone affects cellular calcium ion homeostasis] which results in increased import of Calcium]",affects^phenotype|decreases^reaction|increases^import
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,cellular calcium ion homeostasis,GO:0006874,Calcium^D002118^MESH|RU 1968^C104063^MESH,Homo sapiens,9606.0,"RU 1968 inhibits the reaction [[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects cellular calcium ion homeostasis] which results in increased import of Calcium]",affects^phenotype|decreases^reaction|increases^import
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,DNA-binding transcription factor activity,GO:0003700,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in increased DNA-binding transcription factor activity",increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,embryo development,GO:0009790,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects embryo development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,embryo development,GO:0009790,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene^C000705689^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects embryo development] which affects embryonic body morphogenesis",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,embryo development,GO:0009790,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene^C000705689^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects embryo development] which affects heart development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,embryonic body morphogenesis,GO:0010172,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene^C000705689^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects embryo development] which affects embryonic body morphogenesis",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,embryonic body morphogenesis,GO:0010172,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects embryonic body morphogenesis",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,glutathione metabolic process,GO:0006749,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects glutathione metabolic process",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,glutathione metabolic process,GO:0006749,Glutathione^D005978^MESH,Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects glutathione metabolic process] which results in increased abundance of Glutathione",affects^phenotype|increases^abundance
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,glutathione peroxidase activity,GO:0004602,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in increased glutathione peroxidase activity",increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,heart development,GO:0007507,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene^C000705689^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects embryo development] which affects heart development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,heart development,GO:0007507,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects heart development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,larval development,GO:0002164,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in decreased larval development",decreases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,lipid droplet formation,GO:0140042,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in increased lipid droplet formation",increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,lipid oxidation,GO:0034440,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects lipid oxidation",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,lipid oxidation,GO:0034440,Malondialdehyde^D008315^MESH,Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects lipid oxidation] which results in increased abundance of Malondialdehyde",affects^phenotype|increases^abundance
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,mushroom body development,GO:0016319,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects mushroom body development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,negative gravitaxis,GO:0048060,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in decreased negative gravitaxis",decreases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,negative regulation of cell population proliferation,GO:0008285,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in increased negative regulation of cell population proliferation",increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,negative regulation of histone deacetylase activity,GO:1901726,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in increased negative regulation of histone deacetylase activity",increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,positive regulation of estradiol secretion,GO:2000866,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in increased positive regulation of estradiol secretion",increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,positive regulation of intracellular estrogen receptor signaling pathway,GO:0033148,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in increased positive regulation of intracellular estrogen receptor signaling pathway",increases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,pupation,GO:0035074,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects pupation",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,social behavior,GO:0035176,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects social behavior",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,social behavior,GO:0035176,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene results in decreased social behavior",decreases^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,superoxide dismutase activity,GO:0004784,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects superoxide dismutase activity",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,testosterone biosynthetic process,GO:0061370,,Rattus norvegicus,10116.0,"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects testosterone biosynthetic process",affects^phenotype
"1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene",C000705689,,testosterone biosynthetic process,GO:0061370,Testosterone^D013739^MESH,Rattus norvegicus,10116.0,"[1,1-bis(4-hydroxyphenyl)-2,2-dichloroethylene affects testosterone biosynthetic process] which results in decreased abundance of Testosterone",affects^phenotype|decreases^abundance
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased cellular metabolic process",decreases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased cellular metabolic process",decreases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,embryo development,GO:0009790,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects embryo development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,embryo development,GO:0009790,"1,1-bis(4-hydroxyphenyl)cyclohexane^C517113^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects embryo development] which affects embryonic body morphogenesis",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,embryo development,GO:0009790,"1,1-bis(4-hydroxyphenyl)cyclohexane^C517113^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects embryo development] which affects heart development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,embryo development,GO:0009790,"1,1-bis(4-hydroxyphenyl)cyclohexane^C517113^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects embryo development] which results in decreased swim bladder inflation",affects^phenotype|decreases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,embryonic body morphogenesis,GO:0010172,"1,1-bis(4-hydroxyphenyl)cyclohexane^C517113^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects embryo development] which affects embryonic body morphogenesis",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,embryonic body morphogenesis,GO:0010172,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects embryonic body morphogenesis",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,glutathione metabolic process,GO:0006749,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects glutathione metabolic process",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,glutathione metabolic process,GO:0006749,Glutathione^D005978^MESH,Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects glutathione metabolic process] which results in increased abundance of Glutathione",affects^phenotype|increases^abundance
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,glutathione peroxidase activity,GO:0004602,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased glutathione peroxidase activity",increases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,heart development,GO:0007507,"1,1-bis(4-hydroxyphenyl)cyclohexane^C517113^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects embryo development] which affects heart development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,larval development,GO:0002164,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased larval development",decreases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,lipid oxidation,GO:0034440,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects lipid oxidation",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,lipid oxidation,GO:0034440,Malondialdehyde^D008315^MESH,Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects lipid oxidation] which affects the abundance of Malondialdehyde",affects^abundance|affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,mushroom body development,GO:0016319,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects mushroom body development",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,negative gravitaxis,GO:0048060,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased negative gravitaxis",decreases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,neuron projection extension,GO:1990138,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects neuron projection extension",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,positive regulation of cell death,GO:0010942,,Gallus gallus,9031.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased positive regulation of cell death",increases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,positive regulation of cell population proliferation,GO:0008284,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased positive regulation of cell population proliferation",increases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,positive regulation of cell population proliferation,GO:0008284,Triiodothyronine^D014284^MESH,Rattus norvegicus,10116.0,"1,1-bis(4-hydroxyphenyl)cyclohexane promotes the reaction [Triiodothyronine results in increased positive regulation of cell population proliferation]",increases^phenotype|increases^reaction
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,positive regulation of cell population proliferation,GO:0008284,,Rattus norvegicus,10116.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased positive regulation of cell population proliferation",increases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,positive regulation of intracellular estrogen receptor signaling pathway,GO:0033148,,Homo sapiens,9606.0,"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased positive regulation of intracellular estrogen receptor signaling pathway",increases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,positive regulation of intracellular estrogen receptor signaling pathway,GO:0033148,Fulvestrant^D000077267^MESH,Homo sapiens,9606.0,"Fulvestrant inhibits the reaction [1,1-bis(4-hydroxyphenyl)cyclohexane results in increased positive regulation of intracellular estrogen receptor signaling pathway]",decreases^reaction|increases^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,pupation,GO:0035074,,Drosophila melanogaster,7227.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects pupation",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,superoxide dismutase activity,GO:0004784,,Danio rerio,7955.0,"1,1-bis(4-hydroxyphenyl)cyclohexane affects superoxide dismutase activity",affects^phenotype
"1,1-bis(4-hydroxyphenyl)cyclohexane",C517113,,swim bladder inflation,GO:0048798,"1,1-bis(4-hydroxyphenyl)cyclohexane^C517113^MESH",Danio rerio,7955.0,"[1,1-bis(4-hydroxyphenyl)cyclohexane affects embryo development] which results in decreased swim bladder inflation",affects^phenotype|decreases^phenotype
11-dehydrocorticosterone,C003552,72-23-1,regulation of metabolic process,GO:0019222,Cisplatin^D002945^MESH,Rattus norvegicus,10116.0,[Cisplatin affects regulation of metabolic process] which results in increased abundance of 11-dehydrocorticosterone,affects^phenotype|increases^abundance
11-dehydrocorticosterone,C003552,72-23-1,steroid metabolic process,GO:0008202,Heroin^D003932^MESH,Mus musculus,10090.0,[Heroin affects steroid metabolic process] which results in decreased abundance of 11-dehydrocorticosterone,affects^phenotype|decreases^abundance
11-dehydro-thromboxane B2,C049235,67910-12-7,arachidonic acid metabolic process,GO:0019369,Tetrachlorodibenzodioxin^D013749^MESH,Rattus norvegicus,10116.0,[Tetrachlorodibenzodioxin results in increased arachidonic acid metabolic process] which results in increased abundance of 11-dehydro-thromboxane B2,increases^abundance|increases^phenotype
"11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2",C025088,74158-09-1,arachidonic acid metabolic process,GO:0019369,"11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2^C025088^MESH|Tetrachlorodibenzodioxin^D013749^MESH",Rattus norvegicus,10116.0,"[[Tetrachlorodibenzodioxin results in increased arachidonic acid metabolic process] which results in increased prostanoid metabolic process] which results in increased abundance of 11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2",increases^abundance|increases^phenotype
"11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2",C025088,74158-09-1,prostanoid metabolic process,GO:0006692,"11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2^C025088^MESH|Tetrachlorodibenzodioxin^D013749^MESH",Rattus norvegicus,10116.0,"[[Tetrachlorodibenzodioxin results in increased arachidonic acid metabolic process] which results in increased prostanoid metabolic process] which results in increased abundance of 11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2",increases^abundance|increases^phenotype
11-deoxyprostaglandin E1,C034008,37786-00-8,cell chemotaxis,GO:0060326,,Homo sapiens,9606.0,11-deoxyprostaglandin E1 results in decreased cell chemotaxis,decreases^phenotype
11-deoxyprostaglandin E1,C034008,37786-00-8,histamine secretion mediated by immunoglobulin,GO:0097280,,Homo sapiens,9606.0,11-deoxyprostaglandin E1 results in increased histamine secretion mediated by immunoglobulin,increases^phenotype
11-deoxyprostaglandin E1,C034008,37786-00-8,vasodilation,GO:0042311,,Rattus norvegicus,10116.0,11-deoxyprostaglandin E1 results in increased vasodilation,increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,negative regulation of vasoconstriction,GO:0045906,,Mus musculus,10090.0,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased negative regulation of vasoconstriction",increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,negative regulation of vasoconstriction,GO:0045906,APOE^348^GENE,Mus musculus,10090.0,"APOE gene mutant form inhibits the reaction [1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased negative regulation of vasoconstriction]",decreases^reaction|increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,negative regulation of vasoconstriction,GO:0045906,APOE^348^GENE|manganese(III)-tetrakis(4-benzoic acid)porphyrin^C097284^MESH,Mus musculus,10090.0,"manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [APOE gene mutant form inhibits the reaction [1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased negative regulation of vasoconstriction]]",decreases^reaction|increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,negative regulation of vasoconstriction,GO:0045906,,Rattus norvegicus,10116.0,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased negative regulation of vasoconstriction",increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,negative regulation of vasoconstriction,GO:0045906,chromium mesoporphyrin^C427471^MESH|Particulate Matter^D052638^MESH,Rattus norvegicus,10116.0,"chromium mesoporphyrin inhibits the reaction [Particulate Matter inhibits the reaction [1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased negative regulation of vasoconstriction]]",decreases^reaction|increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,negative regulation of vasoconstriction,GO:0045906,cobaltiprotoporphyrin^C007095^MESH,Rattus norvegicus,10116.0,"cobaltiprotoporphyrin inhibits the reaction [1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased negative regulation of vasoconstriction]",decreases^reaction|increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,negative regulation of vasoconstriction,GO:0045906,Particulate Matter^D052638^MESH,Rattus norvegicus,10116.0,"Particulate Matter inhibits the reaction [1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased negative regulation of vasoconstriction]",decreases^reaction|increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,positive regulation of guanylate cyclase activity,GO:0031284,,Homo sapiens,9606.0,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased positive regulation of guanylate cyclase activity",increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,relaxation of vascular associated smooth muscle,GO:0060087,GPX1^2876^GENE,Mus musculus,10090.0,"[GPX1 gene mutant form results in decreased susceptibility to 1,1-diethyl-2-hydroxy-2-nitrosohydrazine] which results in decreased relaxation of vascular associated smooth muscle",decreases^phenotype|decreases^response to substance
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,vasodilation,GO:0042311,Norepinephrine^D009638^MESH,Mus musculus,10090.0,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine inhibits the reaction [Norepinephrine results in decreased vasodilation]",decreases^phenotype|decreases^reaction
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,vasodilation,GO:0042311,,Mus musculus,10090.0,"1,1-diethyl-2-hydroxy-2-nitrosohydrazine results in increased vasodilation",increases^phenotype
"1,1-diethyl-2-hydroxy-2-nitrosohydrazine",C084012,86831-65-4,vasodilation,GO:0042311,"1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one^C095284^MESH|Norepinephrine^D009638^MESH",Mus musculus,10090.0,"1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [1,1-diethyl-2-hydroxy-2-nitrosohydrazine inhibits the reaction [Norepinephrine results in decreased vasodilation]]",decreases^phenotype|decreases^reaction
"1,1'-diheptyl-4,4'-bipyridinium",C523784,,calcium ion homeostasis,GO:0055074,"2,2',3,5',6-pentachlorobiphenyl^C032904^MESH",Rattus norvegicus,10116.0,"1,1'-diheptyl-4,4'-bipyridinium inhibits the reaction [2,2',3,5',6-pentachlorobiphenyl affects calcium ion homeostasis]",affects^phenotype|decreases^reaction
"1,1'-diheptyl-4,4'-bipyridinium",C523784,,calcium ion homeostasis,GO:0055074,"2,2',4,4'-tetrabromodiphenyl ether^C511295^MESH",Rattus norvegicus,10116.0,"1,1'-diheptyl-4,4'-bipyridinium inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether affects calcium ion homeostasis]",affects^phenotype|decreases^reaction
"1,1'-diheptyl-4,4'-bipyridinium",C523784,,calcium ion homeostasis,GO:0055074,6-OH-BDE-47^C580599^MESH,Rattus norvegicus,10116.0,"1,1'-diheptyl-4,4'-bipyridinium inhibits the reaction [6-OH-BDE-47 affects calcium ion homeostasis]",affects^phenotype|decreases^reaction
"1,1'-diheptyl-4,4'-bipyridinium",C523784,,calcium ion homeostasis,GO:0055074,Chlorpyrifos^D004390^MESH,Rattus norvegicus,10116.0,"1,1'-diheptyl-4,4'-bipyridinium inhibits the reaction [Chlorpyrifos affects calcium ion homeostasis]",affects^phenotype|decreases^reaction
"1,1'-diheptyl-4,4'-bipyridinium",C523784,,calcium ion homeostasis,GO:0055074,Dibutyl Phthalate^D003993^MESH,Rattus norvegicus,10116.0,"1,1'-diheptyl-4,4'-bipyridinium inhibits the reaction [Dibutyl Phthalate affects calcium ion homeostasis]",affects^phenotype|decreases^reaction
"1,1'-diheptyl-4,4'-bipyridinium",C523784,,calcium ion homeostasis,GO:0055074,Diethylhexyl Phthalate^D004051^MESH,Rattus norvegicus,10116.0,"1,1'-diheptyl-4,4'-bipyridinium inhibits the reaction [Diethylhexyl Phthalate affects calcium ion homeostasis]",affects^phenotype|decreases^reaction
"1,1'-diheptyl-4,4'-bipyridinium",C523784,,calcium ion homeostasis,GO:0055074,perfluorooctane sulfonic acid^C076994^MESH,Rattus norvegicus,10116.0,"1,1'-diheptyl-4,4'-bipyridinium inhibits the reaction [perfluorooctane sulfonic acid affects calcium ion homeostasis]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,actin cytoskeleton organization,GO:0030036,,Homo sapiens,9606.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC affects actin cytoskeleton organization",affects^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,activation of adenylate cyclase activity,GO:0007190,CNR2^1269^GENE|Colforsin^D005576^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC binds to and results in increased activity of CNR2 protein] inhibits the reaction [Colforsin results in increased activation of adenylate cyclase activity]",affects^binding|decreases^reaction|increases^activity|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,activation of adenylate cyclase activity,GO:0007190,CNR2^1269^GENE|Colforsin^D005576^MESH|Cyclic AMP^D000242^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC binds to and results in increased activity of CNR2 protein] inhibits the reaction [[Colforsin results in increased activation of adenylate cyclase activity] which results in increased abundance of Cyclic AMP]",affects^binding|decreases^reaction|increases^abundance|increases^activity|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,GO:0007197,CNR2^1269^GENE,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC binds to and results in increased activity of CNR2 protein] which results in increased adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway",affects^binding|increases^activity|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,adipose tissue development,GO:0060612,Dietary Fats^D004041^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats results in increased adipose tissue development]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,adipose tissue development,GO:0060612,Dietary Fats^D004041^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats results in increased adipose tissue development]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,adipose tissue development,GO:0060612,Dietary Fats^D004041^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats results in increased adipose tissue development]]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,adipose tissue development,GO:0060612,Dietary Fats^D004041^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats results in increased adipose tissue development]]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,behavioral response to pain,GO:0048266,LEPR^3953^GENE|sulforaphane^C016766^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC co-treated with sulforaphane] inhibits the reaction [LEPR protein affects behavioral response to pain]",affects^cotreatment|affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,behavioral response to pain,GO:0048266,LEPR^3953^GENE,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [LEPR protein affects behavioral response to pain]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,behavioral response to pain,GO:0048266,cobaltiprotoporphyrin^C007095^MESH|LEPR^3953^GENE,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC promotes the reaction [cobaltiprotoporphyrin inhibits the reaction [LEPR protein affects behavioral response to pain]]",affects^phenotype|decreases^reaction|increases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,behavioral response to pain,GO:0048266,iodopravadoline^C094023^MESH|LEPR^3953^GENE,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [LEPR protein affects behavioral response to pain]]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cAMP metabolic process,GO:0046058,Colforsin^D005576^MESH|Cyclic AMP^D000242^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Colforsin affects cAMP metabolic process] which results in increased abundance of Cyclic AMP]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cAMP metabolic process,GO:0046058,Colforsin^D005576^MESH|Cyclic AMP^D000242^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Colforsin affects cAMP metabolic process] which results in increased abundance of Cyclic AMP]]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cAMP metabolic process,GO:0046058,Colforsin^D005576^MESH|Cyclic AMP^D000242^MESH,Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Colforsin affects cAMP metabolic process] which results in increased abundance of Cyclic AMP]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cAMP metabolic process,GO:0046058,Cyclic AMP^D000242^MESH|F2^2147^GENE,Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[F2 protein affects cAMP metabolic process] which results in decreased abundance of Cyclic AMP]",affects^phenotype|decreases^abundance|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cAMP metabolic process,GO:0046058,Colforsin^D005576^MESH|Cyclic AMP^D000242^MESH|iodopravadoline^C094023^MESH,Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Colforsin affects cAMP metabolic process] which results in increased abundance of Cyclic AMP]]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cAMP metabolic process,GO:0046058,Cyclic AMP^D000242^MESH|F2^2147^GENE|iodopravadoline^C094023^MESH,Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[F2 protein affects cAMP metabolic process] which results in decreased abundance of Cyclic AMP]]",affects^phenotype|decreases^abundance|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cell motility,GO:0048870,iodopravadoline^C094023^MESH,Homo sapiens,9606.0,"[iodopravadoline co-treated with 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC] results in increased cell motility",affects^cotreatment|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cellular metabolic process,GO:0044237,"lipopolysaccharide, E coli O55-B5^C482199^MESH",Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased cellular metabolic process]",decreases^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,cellular metabolic process,GO:0044237,"iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH",Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased cellular metabolic process]]",decreases^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import",increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import",increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import",increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import",increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import",increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,"2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose^C098340^MESH",Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose",increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Deoxyglucose^D003847^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Deoxyglucose",increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Deoxyglucose^D003847^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Deoxyglucose",increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Fluorodeoxyglucose F18^D019788^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Fluorodeoxyglucose F18",increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Fluorodeoxyglucose F18^D019788^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Fluorodeoxyglucose F18",increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Fluorodeoxyglucose F18^D019788^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Fluorodeoxyglucose F18",increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Glucose^D005947^MESH,Mus musculus,10090.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Glucose",increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,CNR1^1268^GENE,Mus musculus,10090.0,"CNR1 protein affects the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import]",affects^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Deoxyglucose^D003847^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Deoxyglucose]",decreases^reaction|increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Deoxyglucose^D003847^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Deoxyglucose]",decreases^reaction|increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glucose import,GO:0046323,Glucose^D005947^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in increased glucose import] which results in increased import of Glucose]",decreases^reaction|increases^import|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glutathione metabolic process,GO:0006749,"Glutathione^D005978^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH",Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects glutathione metabolic process] which results in decreased abundance of Glutathione]",affects^phenotype|decreases^abundance|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glutathione metabolic process,GO:0006749,"Glutathione^D005978^MESH|iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH",Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects glutathione metabolic process] which results in decreased abundance of Glutathione]]",affects^phenotype|decreases^abundance|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glutathione metabolic process,GO:0006749,"Glutathione^D005978^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH",Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects glutathione metabolic process] which results in decreased abundance of Glutathione]",affects^phenotype|decreases^abundance|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,glutathione metabolic process,GO:0006749,"Glutathione^D005978^MESH|iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH",Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects glutathione metabolic process] which results in decreased abundance of Glutathione]]",affects^phenotype|decreases^abundance|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,inflammatory response,GO:0006954,Dietary Fats^D004041^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats results in increased inflammatory response]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,leukocyte adhesion to vascular endothelial cell,GO:0061756,TNF^7124^GENE,Homo sapiens,9606.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [TNF protein results in increased leukocyte adhesion to vascular endothelial cell]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,leukocyte cell-cell adhesion,GO:0007159,Lipopolysaccharides^D008070^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Lipopolysaccharides results in increased leukocyte cell-cell adhesion]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,leukocyte cell-cell adhesion,GO:0007159,Lipopolysaccharides^D008070^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Lipopolysaccharides results in increased leukocyte cell-cell adhesion]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,leukocyte cell-cell adhesion,GO:0007159,CNR2^1269^GENE|Lipopolysaccharides^D008070^MESH,Mus musculus,10090.0,"CNR2 protein affects the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Lipopolysaccharides results in increased leukocyte cell-cell adhesion]]",affects^reaction|decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,leukocyte cell-cell adhesion,GO:0007159,Lipopolysaccharides^D008070^MESH|SR 144528^C110630^MESH,Mus musculus,10090.0,"SR 144528 inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Lipopolysaccharides results in increased leukocyte cell-cell adhesion]]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,leukocyte migration involved in inflammatory response,GO:0002523,Paraquat^D010269^MESH,Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Paraquat results in increased leukocyte migration involved in inflammatory response]",decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,maintenance of blood-brain barrier,GO:0035633,Lipopolysaccharides^D008070^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Lipopolysaccharides affects maintenance of blood-brain barrier]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,microglial cell proliferation,GO:0061518,Ethanol^D000431^MESH,Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Ethanol results in decreased microglial cell proliferation]",decreases^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,microglial cell proliferation,GO:0061518,,Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC results in decreased microglial cell proliferation",decreases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,microglial cell proliferation,GO:0061518,Ethanol^D000431^MESH,Rattus norvegicus,10116.0,"[Ethanol co-treated with 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC] results in increased microglial cell proliferation",affects^cotreatment|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,microglial cell proliferation,GO:0061518,Ethanol^D000431^MESH,Rattus norvegicus,10116.0,"[Ethanol co-treated with 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC] results in increased microglial cell proliferation",affects^cotreatment|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic cell cycle process,GO:1903047,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in decreased mitotic S phase]",affects^phenotype|decreases^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic cell cycle process,GO:1903047,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in increased mitotic G1 phase]",affects^phenotype|decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic cell cycle process,GO:1903047,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|iodopravadoline^C094023^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in decreased mitotic S phase]]",affects^phenotype|decreases^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic cell cycle process,GO:1903047,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|iodopravadoline^C094023^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in increased mitotic G1 phase]]",affects^phenotype|decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic G1 phase,GO:0000080,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in increased mitotic G1 phase]",affects^phenotype|decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic G1 phase,GO:0000080,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|iodopravadoline^C094023^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in increased mitotic G1 phase]]",affects^phenotype|decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic S phase,GO:0000084,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in decreased mitotic S phase]",affects^phenotype|decreases^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,mitotic S phase,GO:0000084,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|iodopravadoline^C094023^MESH|Magnesium^D008274^MESH",Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[Magnesium deficiency affects mitotic cell cycle process] which results in decreased mitotic S phase]]",affects^phenotype|decreases^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,monoatomic ion channel activity,GO:0005216,TRH^7200^GENE,Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC promotes the reaction [TRH protein results in increased monoatomic ion channel activity]",increases^phenotype|increases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,nitric oxide metabolic process,GO:0046209,"lipopolysaccharide, E coli O55-B5^C482199^MESH|Nitric Oxide^D009569^MESH",Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects nitric oxide metabolic process] which results in increased abundance of Nitric Oxide]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,nitric oxide metabolic process,GO:0046209,"iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH|Nitric Oxide^D009569^MESH",Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects nitric oxide metabolic process] which results in increased abundance of Nitric Oxide]]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,nitric oxide transport,GO:0030185,"lipopolysaccharide, E coli O55-B5^C482199^MESH|Nitric Oxide^D009569^MESH",Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects nitric oxide transport] which results in increased secretion of Nitric Oxide]",affects^phenotype|decreases^reaction|increases^secretion
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,nitric oxide transport,GO:0030185,"iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH|Nitric Oxide^D009569^MESH",Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects nitric oxide transport] which results in increased secretion of Nitric Oxide]]",affects^phenotype|decreases^reaction|increases^secretion
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,prostaglandin secretion,GO:0032310,"Dinoprostone^D015232^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH",Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects prostaglandin secretion] which results in increased secretion of Dinoprostone]",affects^phenotype|decreases^reaction|increases^secretion
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,prostaglandin secretion,GO:0032310,"Dinoprostone^D015232^MESH|iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH",Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects prostaglandin secretion] which results in increased secretion of Dinoprostone]]",affects^phenotype|decreases^reaction|increases^secretion
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,reactive oxygen species metabolic process,GO:0072593,,Homo sapiens,9606.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC affects reactive oxygen species metabolic process",affects^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,reactive oxygen species metabolic process,GO:0072593,Reactive Oxygen Species^D017382^MESH,Homo sapiens,9606.0,"[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC affects reactive oxygen species metabolic process] which results in increased abundance of Reactive Oxygen Species",affects^phenotype|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,reactive oxygen species metabolic process,GO:0072593,iodopravadoline^C094023^MESH|Reactive Oxygen Species^D017382^MESH,Homo sapiens,9606.0,"iodopravadoline inhibits the reaction [[1,1-dimethylbutyl-1-deoxy-Delta(9)-THC affects reactive oxygen species metabolic process] which results in increased abundance of Reactive Oxygen Species]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,reactive oxygen species metabolic process,GO:0072593,"lipopolysaccharide, E coli O55-B5^C482199^MESH|Reactive Oxygen Species^D017382^MESH",Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects reactive oxygen species metabolic process] which results in increased abundance of Reactive Oxygen Species]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,reactive oxygen species metabolic process,GO:0072593,"iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH|Reactive Oxygen Species^D017382^MESH",Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects reactive oxygen species metabolic process] which results in increased abundance of Reactive Oxygen Species]]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,reactive oxygen species metabolic process,GO:0072593,"lipopolysaccharide, E coli O55-B5^C482199^MESH|Reactive Oxygen Species^D017382^MESH",Rattus norvegicus,10116.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects reactive oxygen species metabolic process] which results in increased abundance of Reactive Oxygen Species]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,reactive oxygen species metabolic process,GO:0072593,"iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH|Reactive Oxygen Species^D017382^MESH",Rattus norvegicus,10116.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects reactive oxygen species metabolic process] which results in increased abundance of Reactive Oxygen Species]]",affects^phenotype|decreases^reaction|increases^abundance
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,regulation of cell size,GO:0008361,Dietary Fats^D004041^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats affects regulation of cell size]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,regulation of cell size,GO:0008361,Dietary Fats^D004041^MESH,Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats affects regulation of cell size]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,regulation of cell size,GO:0008361,Dietary Fats^D004041^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats affects regulation of cell size]]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,regulation of cell size,GO:0008361,Dietary Fats^D004041^MESH|iodopravadoline^C094023^MESH,Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [Dietary Fats affects regulation of cell size]]",affects^phenotype|decreases^reaction
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,regulation of membrane permeability,GO:0090559,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|TNF^7124^GENE",Homo sapiens,9606.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[TNF protein affects regulation of membrane permeability] which results in increased transepithelial transport]",affects^phenotype|decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,transepithelial transport,GO:0070633,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC^C432747^MESH|TNF^7124^GENE",Homo sapiens,9606.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[TNF protein affects regulation of membrane permeability] which results in increased transepithelial transport]",affects^phenotype|decreases^reaction|increases^phenotype
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,urea transport,GO:0015840,"lipopolysaccharide, E coli O55-B5^C482199^MESH|Urea^D014508^MESH",Mus musculus,10090.0,"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects urea transport] which results in decreased secretion of Urea]",affects^phenotype|decreases^reaction|decreases^secretion
"1,1-dimethylbutyl-1-deoxy-Delta(9)-THC",C432747,,urea transport,GO:0015840,"iodopravadoline^C094023^MESH|lipopolysaccharide, E coli O55-B5^C482199^MESH|Urea^D014508^MESH",Mus musculus,10090.0,"iodopravadoline inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [[lipopolysaccharide, E coli O55-B5 affects urea transport] which results in decreased secretion of Urea]]",affects^phenotype|decreases^reaction|decreases^secretion
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,cell redox homeostasis,GO:0045454,Resveratrol^D000077185^MESH,,,"[Resveratrol analog results in increased cell redox homeostasis] which results in decreased abundance of 1,1-diphenyl-2-picrylhydrazyl",decreases^abundance|increases^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,cell redox homeostasis,GO:0045454,Resveratrol^D000077185^MESH,,,"[Resveratrol results in increased cell redox homeostasis] which results in decreased abundance of 1,1-diphenyl-2-picrylhydrazyl",decreases^abundance|increases^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,cellular oxidant detoxification,GO:0098869,Ascorbic Acid^D001205^MESH|Free Radicals^D005609^MESH,Homo sapiens,9606.0,"[[Ascorbic Acid binds to Free Radicals] which results in increased cellular oxidant detoxification] which results in decreased abundance of 1,1-diphenyl-2-picrylhydrazyl",affects^binding|decreases^abundance|increases^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,glutathione metabolic process,GO:0006749,,Mus musculus,10090.0,"1,1-diphenyl-2-picrylhydrazyl affects glutathione metabolic process",affects^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,glutathione metabolic process,GO:0006749,Glutathione^D005978^MESH,Mus musculus,10090.0,"[1,1-diphenyl-2-picrylhydrazyl affects glutathione metabolic process] which results in decreased abundance of Glutathione",affects^phenotype|decreases^abundance
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,glutathione peroxidase activity,GO:0004602,,Mus musculus,10090.0,"1,1-diphenyl-2-picrylhydrazyl results in decreased glutathione peroxidase activity",decreases^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,L-aspartate:2-oxoglutarate aminotransferase activity,GO:0004069,,Mus musculus,10090.0,"1,1-diphenyl-2-picrylhydrazyl results in increased L-aspartate:2-oxoglutarate aminotransferase activity",increases^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,lipid oxidation,GO:0034440,,Mus musculus,10090.0,"1,1-diphenyl-2-picrylhydrazyl results in increased lipid oxidation",increases^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,lipid oxidation,GO:0034440,Malondialdehyde^D008315^MESH,Mus musculus,10090.0,"[1,1-diphenyl-2-picrylhydrazyl results in increased lipid oxidation] which results in increased abundance of Malondialdehyde",increases^abundance|increases^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,nitric oxide metabolic process,GO:0046209,,Mus musculus,10090.0,"1,1-diphenyl-2-picrylhydrazyl affects nitric oxide metabolic process",affects^phenotype
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,nitric oxide metabolic process,GO:0046209,Nitric Oxide^D009569^MESH,Mus musculus,10090.0,"[1,1-diphenyl-2-picrylhydrazyl affects nitric oxide metabolic process] which results in increased abundance of Nitric Oxide",affects^phenotype|increases^abundance
"1,1-diphenyl-2-picrylhydrazyl",C004931,1898-66-4,superoxide dismutase activity,GO:0004784,,Mus musculus,10090.0,"1,1-diphenyl-2-picrylhydrazyl results in decreased superoxide dismutase activity",decreases^phenotype
"1,1-diphenylhydrazine",C037220,530-50-7,negative regulation of cell population proliferation,GO:0008285,CYP2C9^1559^GENE,Homo sapiens,9606.0,"[CYP2C9 mRNA results in increased susceptibility to 1,1-diphenylhydrazine] which results in increased negative regulation of cell population proliferation",increases^phenotype|increases^response to substance
"11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol",C541120,,myotube differentiation,GO:0014902,Albuterol^D000420^MESH,Mus musculus,10090.0,"11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol inhibits the reaction [Albuterol affects myotube differentiation]",affects^phenotype|decreases^reaction
"11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol",C541120,,myotube differentiation,GO:0014902,Estradiol^D004958^MESH,Mus musculus,10090.0,"11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol inhibits the reaction [Estradiol affects myotube differentiation]",affects^phenotype|decreases^reaction
"11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol",C541120,,myotube differentiation,GO:0014902,Formoterol Fumarate^D000068759^MESH,Mus musculus,10090.0,"11-fluoro-7-(14,14,15,15-pentafluoro-6-methyl-10-thia-6-azapentadecyl)estra-1,3-5(10)-triene-3,17-diol inhibits the reaction [Formoterol Fumarate affects myotube differentiation]",affects^phenotype|decreases^reaction
"11-hydroxy-5,8,12,14-eicosatetraenoic acid",C027356,73151-66-3,fatty acid metabolic process,GO:0006631,Glyphosate^D000097797^MESH,Mus musculus,10090.0,"[Glyphosate affects fatty acid metabolic process] which results in decreased abundance of 11-hydroxy-5,8,12,14-eicosatetraenoic acid analog",affects^phenotype|decreases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxy-delta(9)-tetrahydrocannabinol,C001427,26108-40-7,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-hydroxy-delta(9)-tetrahydrocannabinol,affects^phenotype|increases^abundance
11-hydroxyprogesterone,C030228,312-90-3,regulation of metabolic process,GO:0019222,Soot^D053260^MESH,Rattus norvegicus,10116.0,[Soot affects regulation of metabolic process] which results in decreased abundance of 11-hydroxyprogesterone,affects^phenotype|decreases^abundance
11-hydroxyprogesterone 11-glucuronide,C061068,129238-72-8,regulation of cellular metabolic process,GO:0031323,deoxynivalenol^C007262^MESH,Sus scrofa,9823.0,[deoxynivalenol affects regulation of cellular metabolic process] which results in decreased abundance of 11-hydroxyprogesterone 11-glucuronide,affects^phenotype|decreases^abundance
11-hydroxytestosterone,C037914,1816-85-9,androgen metabolic process,GO:0008209,Ketoconazole^D007654^MESH,Equus caballus,9796.0,[Ketoconazole results in decreased androgen metabolic process] which results in decreased chemical synthesis of 11-hydroxytestosterone,decreases^chemical synthesis|decreases^phenotype
11-hydroxytestosterone,C037914,1816-85-9,androgen metabolic process,GO:0008209,Quercetin^D011794^MESH,Equus caballus,9796.0,[Quercetin results in decreased androgen metabolic process] which results in decreased chemical synthesis of 11-hydroxytestosterone,decreases^chemical synthesis|decreases^phenotype
11-hydroxytestosterone,C037914,1816-85-9,androgen metabolic process,GO:0008209,Troleandomycin^D014217^MESH,Equus caballus,9796.0,[Troleandomycin results in decreased androgen metabolic process] which results in decreased chemical synthesis of 11-hydroxytestosterone,decreases^chemical synthesis|decreases^phenotype
"1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine",C000593259,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine results in decreased cellular metabolic process",decreases^phenotype
"1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine",C000593259,,cellular metabolic process,GO:0044237,,Homo sapiens,9606.0,"1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine results in decreased cellular metabolic process",decreases^phenotype
11-ketotestosterone,C003600,53187-98-7,androgen metabolic process,GO:0008209,bisphenol A^C006780^MESH,Gobiocypris rarus,143606.0,[bisphenol A affects androgen metabolic process] which results in increased abundance of 11-ketotestosterone,affects^phenotype|increases^abundance
11-ketotestosterone,C003600,53187-98-7,androgen receptor signaling pathway,GO:0030521,,Gnathopogon caerulescens,435243.0,11-ketotestosterone results in increased androgen receptor signaling pathway,increases^phenotype
11-ketotestosterone,C003600,53187-98-7,locomotory behavior,GO:0007626,,Danio rerio,7955.0,11-ketotestosterone affects locomotory behavior,affects^phenotype
11-ketotestosterone,C003600,53187-98-7,negative regulation of androgen secretion,GO:2000835,bisphenol A^C006780^MESH,Amphiprion ocellaris,80972.0,[bisphenol A results in increased negative regulation of androgen secretion] which results in decreased secretion of 11-ketotestosterone,decreases^secretion|increases^phenotype
11-ketotestosterone,C003600,53187-98-7,negative regulation of androgen secretion,GO:2000835,Ethinyl Estradiol^D004997^MESH,Amphiprion ocellaris,80972.0,[Ethinyl Estradiol results in increased negative regulation of androgen secretion] which results in decreased abundance of 11-ketotestosterone,decreases^abundance|increases^phenotype
11-ketotestosterone,C003600,53187-98-7,steroid biosynthetic process,GO:0006694,bisphenol A^C006780^MESH,Sparus aurata,8175.0,[bisphenol A affects steroid biosynthetic process] which results in decreased abundance of 11-ketotestosterone,affects^phenotype|decreases^abundance
11-ketotestosterone,C003600,53187-98-7,steroid metabolic process,GO:0008202,"4,4'-hexafluorisopropylidene diphenol^C583074^MESH",Danio rerio,7955.0,"[4,4'-hexafluorisopropylidene diphenol affects steroid metabolic process] which results in increased secretion of 11-ketotestosterone",affects^phenotype|increases^secretion
11-ketotestosterone,C003600,53187-98-7,testosterone biosynthetic process,GO:0061370,Acetaminophen^D000082^MESH,Danio rerio,7955.0,[Acetaminophen affects testosterone biosynthetic process] which results in decreased abundance of 11-ketotestosterone,affects^phenotype|decreases^abundance
1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea,C561619,,cell population proliferation,GO:0008283,Diazepam^D003975^MESH|tetramethylenedisulfotetramine^C010349^MESH,Mus musculus,10090.0,[Diazepam co-treated with 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea] promotes the reaction [tetramethylenedisulfotetramine results in increased cell population proliferation],affects^cotreatment|increases^phenotype|increases^reaction
1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea,C561619,,cellular response to food,GO:0071240,Dietary Fats^D004041^MESH,Mus musculus,10090.0,1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Dietary Fats results in increased cellular response to food],decreases^reaction|increases^phenotype
1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea,C561619,,cellular response to food,GO:0071240,Dietary Fats^D004041^MESH,Mus musculus,10090.0,1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Dietary Fats results in increased cellular response to food],decreases^reaction|increases^phenotype
1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea,C561619,,microglial cell activation,GO:0001774,Diazepam^D003975^MESH|tetramethylenedisulfotetramine^C010349^MESH,Mus musculus,10090.0,[Diazepam co-treated with 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea] inhibits the reaction [tetramethylenedisulfotetramine results in increased microglial cell activation],affects^cotreatment|decreases^reaction|increases^phenotype
11-methyleneprostaglandin D2,C516972,,regulation of metabolic process,GO:0019222,Caffeine^D002110^MESH,Rattus norvegicus,10116.0,[Caffeine affects regulation of metabolic process] which results in increased abundance of 11-methyleneprostaglandin D2,affects^phenotype|increases^abundance
1-(1-naphthyl)piperazine,C048241,57536-86-4,apoptotic process,GO:0006915,,Homo sapiens,9606.0,1-(1-naphthyl)piperazine results in increased apoptotic process,increases^phenotype
1-(1-naphthyl)piperazine,C048241,57536-86-4,cell growth,GO:0016049,,Homo sapiens,9606.0,1-(1-naphthyl)piperazine results in decreased cell growth,decreases^phenotype
1-(1-naphthyl)piperazine,C048241,57536-86-4,negative regulation of colon smooth muscle contraction,GO:1904342,Serotonin^D012701^MESH,Cavia porcellus,10141.0,1-(1-naphthyl)piperazine inhibits the reaction [Serotonin results in increased negative regulation of colon smooth muscle contraction],decreases^reaction|increases^phenotype
1-(1-naphthyl)piperazine,C048241,57536-86-4,negative regulation of mitotic cell cycle,GO:0045930,,Homo sapiens,9606.0,1-(1-naphthyl)piperazine results in increased negative regulation of mitotic cell cycle,increases^phenotype
1-(1-naphthyl)piperazine,C048241,57536-86-4,reactive oxygen species biosynthetic process,GO:1903409,,Homo sapiens,9606.0,1-(1-naphthyl)piperazine results in increased reactive oxygen species biosynthetic process,increases^phenotype
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,DNA methylation on cytosine within a CG sequence,GO:0010424,Cannabinoids^D002186^MESH,Homo sapiens,9606.0,[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects DNA methylation on cytosine within a CG sequence,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,lipid metabolic process,GO:0006629,Dronabinol^D013759^MESH,Mus musculus,10090.0,[Dronabinol affects lipid metabolic process] which results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,affects^phenotype|increases^abundance
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid,C016780,64280-14-4,spermatogenesis,GO:0007283,Cannabinoids^D002186^MESH,Homo sapiens,9606.0,[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which results in decreased spermatogenesis,decreases^phenotype|increases^abundance
11-octadecenoic acid,C050413,143-25-9,lipid metabolic process,GO:0006629,"4,4'-hexafluorisopropylidene diphenol^C583074^MESH",Danio rerio,7955.0,"[4,4'-hexafluorisopropylidene diphenol affects lipid metabolic process] which affects the abundance of 11-octadecenoic acid",affects^abundance|affects^phenotype
11-octadecenoic acid,C050413,143-25-9,lipid metabolic process,GO:0006629,bisphenol A^C006780^MESH,Danio rerio,7955.0,[bisphenol A affects lipid metabolic process] which affects the abundance of 11-octadecenoic acid,affects^abundance|affects^phenotype
11-octadecenoic acid,C050413,143-25-9,lipid metabolic process,GO:0006629,bisphenol B^C492482^MESH,Danio rerio,7955.0,[bisphenol B affects lipid metabolic process] which affects the abundance of 11-octadecenoic acid,affects^abundance|affects^phenotype
11-octadecenoic acid,C050413,143-25-9,lipid metabolic process,GO:0006629,bisphenol F^C000611646^MESH,Danio rerio,7955.0,[bisphenol F affects lipid metabolic process] which affects the abundance of 11-octadecenoic acid,affects^abundance|affects^phenotype
11-octadecenoic acid,C050413,143-25-9,regulation of fatty acid metabolic process,GO:0019217,beta-hexachlorocyclohexane^C023888^MESH,Mus musculus,10090.0,[beta-hexachlorocyclohexane affects regulation of fatty acid metabolic process] which results in increased abundance of 11-octadecenoic acid,affects^phenotype|increases^abundance
11-octadecenoic acid,C050413,143-25-9,regulation of fatty acid metabolic process,GO:0019217,Dichlorodiphenyl Dichloroethylene^D003633^MESH,Mus musculus,10090.0,[Dichlorodiphenyl Dichloroethylene affects regulation of fatty acid metabolic process] which results in increased abundance of 11-octadecenoic acid,affects^phenotype|increases^abundance
1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol,C435044,,positive regulation of p38MAPK cascade,GO:1900745,tricarbonyldichlororuthenium (II) dimer^C447082^MESH,Homo sapiens,9606.0,1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased positive regulation of p38MAPK cascade],decreases^reaction|increases^phenotype
1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol,C435044,,positive regulation of phosphatidylinositol 3-kinase activity,GO:0043552,IL1B^3553^GENE,,,1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [IL1B protein affects positive regulation of phosphatidylinositol 3-kinase activity],affects^phenotype|decreases^reaction
11-oxoeicosatetraenoic acid,C571448,,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,11-oxoeicosatetraenoic acid analog results in decreased cell population proliferation,decreases^phenotype
11-oxoeicosatetraenoic acid,C571448,,cell population proliferation,GO:0008283,,Homo sapiens,9606.0,11-oxoeicosatetraenoic acid results in decreased cell population proliferation,decreases^phenotype
1-(1- pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone,C569194,,action potential,GO:0001508,,Rattus norvegicus,10116.0,1-(1- pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone results in decreased action potential,decreases^phenotype
"12,13-dihydroxyoctadecenoic acid",C425204,,metabolic process,GO:0008152,Plant Extracts^D010936^MESH|Sodium Fluoride^D012969^MESH,Rattus norvegicus,10116.0,"Plant Extracts inhibits the reaction [[Sodium Fluoride affects metabolic process] which results in decreased abundance of 12,13-dihydroxyoctadecenoic acid]",affects^phenotype|decreases^abundance|decreases^reaction
"12,13-dihydroxyoctadecenoic acid",C425204,,metabolic process,GO:0008152,Sodium Fluoride^D012969^MESH,Rattus norvegicus,10116.0,"[Sodium Fluoride affects metabolic process] which results in decreased abundance of 12,13-dihydroxyoctadecenoic acid",affects^phenotype|decreases^abundance
"1,23,25-trihydroxyvitamin D3",C038789,86701-33-9,steroid metabolic process,GO:0008202,sodium arsenate^C009277^MESH,Azumapecten farreri,106299.0,"[sodium arsenate affects steroid metabolic process] which results in decreased abundance of 1,23,25-trihydroxyvitamin D3",affects^phenotype|decreases^abundance
"1,2,3,4,6,7,8-heptachlorodibenzodioxin",C046839,35822-46-9,regulation of blood pressure,GO:0008217,,Homo sapiens,9606.0,"1,2,3,4,6,7,8-heptachlorodibenzodioxin affects regulation of blood pressure",affects^phenotype
"1,2,3,4,6,7,8-heptachlorodibenzofuran",C473650,,regulation of blood pressure,GO:0008217,,Homo sapiens,9606.0,"1,2,3,4,6,7,8-heptachlorodibenzofuran affects regulation of blood pressure",affects^phenotype
"1,2,3,4,6,7,8-heptachlorodibenzofuran",C473650,,triglyceride metabolic process,GO:0006641,,Homo sapiens,9606.0,"1,2,3,4,6,7,8-heptachlorodibenzofuran affects triglyceride metabolic process",affects^phenotype
"1,2,3,4,6,7-hexachlorinated naphthalene",C412791,,cellular response to DNA damage stimulus,GO:0006974,,Homo sapiens,9606.0,"1,2,3,4,6,7-hexachlorinated naphthalene results in increased cellular response to DNA damage stimulus",increases^phenotype
"1,2,3,4,7,8-hexachlorodibenzofuran",C051412,70648-26-9,regulation of blood pressure,GO:0008217,,Homo sapiens,9606.0,"1,2,3,4,7,8-hexachlorodibenzofuran affects regulation of blood pressure",affects^phenotype
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,apoptotic process,GO:0006915,Propofol^D015742^MESH,Rattus norvegicus,10116.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole promotes the reaction [Propofol results in increased apoptotic process],increases^phenotype|increases^reaction
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,calcium ion homeostasis,GO:0055074,Diosgenin^D004144^MESH,Homo sapiens,9606.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Diosgenin affects calcium ion homeostasis],affects^phenotype|decreases^reaction
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,calcium ion homeostasis,GO:0055074,Gallic Acid^D005707^MESH,Homo sapiens,9606.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Gallic Acid affects calcium ion homeostasis],affects^phenotype|decreases^reaction
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,calcium ion homeostasis,GO:0055074,Doxorubicin^D004317^MESH,Rattus norvegicus,10116.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Doxorubicin affects calcium ion homeostasis],affects^phenotype|decreases^reaction
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,calcium ion import,GO:0070509,pyrene^C030984^MESH,Homo sapiens,9606.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [pyrene results in increased calcium ion import],decreases^reaction|increases^phenotype
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,calcium ion import,GO:0070509,Timolol^D013999^MESH,Homo sapiens,9606.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Timolol results in increased calcium ion import],decreases^reaction|increases^phenotype
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,cellular calcium ion homeostasis,GO:0006874,Amitriptyline^D000639^MESH,Homo sapiens,9606.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Amitriptyline affects cellular calcium ion homeostasis],affects^phenotype|decreases^reaction
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,cellular calcium ion homeostasis,GO:0006874,Cytochalasin B^D003571^MESH,Homo sapiens,9606.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Cytochalasin B affects cellular calcium ion homeostasis],affects^phenotype|decreases^reaction
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,cellular calcium ion homeostasis,GO:0006874,Calcium^D002118^MESH|Lipopolysaccharides^D008070^MESH,Mus musculus,10090.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [[Lipopolysaccharides affects cellular calcium ion homeostasis] which results in increased abundance of Calcium],affects^phenotype|decreases^reaction|increases^abundance
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,histamine secretion mediated by immunoglobulin,GO:0097280,GAST^2520^GENE,Rattus norvegicus,10116.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [GAST protein results in increased histamine secretion mediated by immunoglobulin],decreases^reaction|increases^phenotype
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,inorganic cation import across plasma membrane,GO:0098659,AGT^183^GENE,Rattus norvegicus,10116.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [AGT protein modified form results in increased inorganic cation import across plasma membrane],decreases^reaction|increases^phenotype
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,learning,GO:0007612,Propofol^D015742^MESH,Rattus norvegicus,10116.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole promotes the reaction [Propofol affects learning],affects^phenotype|increases^reaction
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,manganese ion transmembrane transport,GO:0071421,ADCYAP1^116^GENE,Bos taurus,9913.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [ADCYAP1 protein modified form results in increased manganese ion transmembrane transport],decreases^reaction|increases^phenotype
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,manganese ion transmembrane transport,GO:0071421,ADCYAP1^116^GENE|Manganese^D008345^MESH,Bos taurus,9913.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [[ADCYAP1 protein modified form results in increased manganese ion transmembrane transport] which results in increased uptake of Manganese],decreases^reaction|increases^phenotype|increases^uptake
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,manganese ion transmembrane transport,GO:0071421,Thapsigargin^D019284^MESH,Bos taurus,9913.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [Thapsigargin results in increased manganese ion transmembrane transport],decreases^reaction|increases^phenotype
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,manganese ion transmembrane transport,GO:0071421,Manganese^D008345^MESH|Thapsigargin^D019284^MESH,Bos taurus,9913.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [[Thapsigargin results in increased manganese ion transmembrane transport] which results in increased uptake of Manganese],decreases^reaction|increases^phenotype|increases^uptake
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,C063159,130495-35-1,memory,GO:0007613,Propofol^D015742^MESH,Rattus norvegicus,10116.0,1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole promotes the reaction [Propofol affects memory],affects^phenotype|increases^reaction
